“What [are] the long-term effects? What will it do to your body? Your mind? What will it do to us five years from now, 10 years from now?” In a video message that left her visibly crying, Mo’Nique addressed the viewers who have seen that the weight-loss injections have left the doctors offices and become a regular topic of discussion.
Her caution was thrown down at a time when GLP-1 drugs, originally designed to assist in maintaining blood sugar levels, have been shorthand in signifying the speedy body transformation, enhanced by social streams and famous outing. Instead of coming out as a clinician, Mo’Nique came out as a person who was attempting to slow down a stampede.
She recognized the attractiveness of expediency in the video when she advised against rushing into things at the expense of careful consideration of the ways the rush can fixate on. And yes, you can be as pretty as a million dollars on the outside. You can go down to that size, two or four or that size eight or whatever that is. But I would advise you to research what you are putting into your body, she said in comments that were underlined in a video that has been posted online. She said that the trend culture can substitute patient deliberation, and further added that they got us sucked in the trends, and that ordinary people are being dragged by the big stars.
Then the message turned from physiology to psychology. “They’re taking away our willpower. They’re taking away our fight. They’re taking away our ability to say, I believe in myself, I’m a trust the process,” she said, before urging viewers to “love yourself enough not to be tricked.” She also added, “I’m not judging nobody’s decision because it is yours,” framing her comments as directed at younger people who may be unsure how to weigh risks and promises.
Mo’Nique is not acting out in emptiness. The science of GLP-1s has grown rapidly, and the usage has so increased that it has created a growing gap between the known and the unknown: What people desire to know about living on these drugs over years. Researchers estimated that semaglutide and tirzepatide have the potential to prevent cases of obesity and diabetes, and cardiovascular diseases in the future in large numbers among U.S adults who are eligible to use them in a lifetime microsimulation study published in 2025. According to the same paper, the average gains in quality-adjusted life-years were modest with semaglutide at 0.25 and tirzepatide at 0.35 and reported that at then-current net prices, they were not cost-effective using the model assumptions.
Abstract compared to the lived experience that people are struggling to transform: sore knees, breathlessness on the stairs, worsening lab results, a lifetime of dieting and gaining. The GLP-1 discussion is thus likely to divide into competing truths medical possibility on one side, unease on the other, lacking a common language as to what “long-term” ought to mean. Trials can quantify weight loss and cardiometabolic risk factors but there are other questions that arise in everyday application: can people adhere to treatment, what occurs when they leave treatment, how work performance and relationships are affected by the side-effects, and how expectations change when the default condition is made to be thin.
In the meantime, the more general obesity-treatment environment keeps picking up. According to industry observers, 2026 is being referred to as an acceleration year in regard to obesity pharmacotherapy with oral preparations and longer acting preparations becoming more like routine medications. Not market momentum is the point that we make towards patients, that decisions that were previously framed as short-term assistance, are now being framed as long-term management.
The video by Mo’Nique, deprived of the clatter surrounding the bodies of celebrities, is a last cry of time, time to inquire what is known, what is unknown, and what is being sacrificed in the madness to appear different. She explained to viewers that she loved them enough to believe their process, not because she said the process was medication, but because it ought to have an informed consent, not the kind where they get before-and-after pictures.
